Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

766
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

683
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

485
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
485
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

413
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
413
Kidney Structure01:45

Kidney Structure

75.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
75.5K
Anatomy of the Intestines01:23

Anatomy of the Intestines

87.9K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
87.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time sensing-integrated organoid-on-a-chip platforms: Technological progress and emerging biomedical applications.

Bioactive materials·2026
Same author

Immune Responses Against Allergic Asthma Following Intervention with <i>Lacticaseibacillus paracasei</i> DMLA16017 and Vitamin D in Rats.

Nutrients·2026
Same author

<i>Atractylodes lancea</i> Polysaccharides Protect against <i>Staphylococcus aureus</i>-Induced Lung Injury by Remodeling Gut Microbiota and Restoring Tryptophan Metabolism.

Journal of agricultural and food chemistry·2026
Same author

A hypoxic microfluidic organoid-on-a-chip system for studying the efficacy of metronidazole-modified nanomaterials against cholangiocarcinoma established within the chip.

Lab on a chip·2026
Same author

Distributed acoustic sensing system utilizing Gaussian-shaped probe pulses for seismic wave detection.

The Review of scientific instruments·2026
Same author

PlantCTCIP: Chromatin Interaction Prediction Using Convolutional Neural Network and Transformer in Plants.

Plant biotechnology journal·2026

Related Experiment Video

Updated: Feb 12, 2026

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K

Intestinal Microbiota and Kidney Diseases.

Ao Xie1, Jie Sheng1, Feng Zheng2

  • 1Advanced Institute for Medical Science, The Second Hosptial, Dalian Medical University, Dalian, Liaoning Province, 116044, China.

Chinese Journal of Integrative Medicine
|April 14, 2018
PubMed
Summary

Kidney diseases are rising, and gut bacteria play a role. Studying gut microbes in kidney disease may reveal new therapeutic targets for conditions like IgA nephropathy and diabetic nephropathy.

Keywords:
IgA nephropathychronic kidney diseasemicrobiotauremia

More Related Videos

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

14.0K
An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
05:27

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

Published on: June 30, 2021

5.1K

Related Experiment Videos

Last Updated: Feb 12, 2026

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.6K
Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

14.0K
An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
05:27

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

Published on: June 30, 2021

5.1K

Area of Science:

  • Microbiology
  • Nephrology
  • Immunology

Background:

  • Kidney diseases are increasingly prevalent globally.
  • The gut microbiota influences host metabolism and immunity.
  • Factors like genetics and diet can alter gut flora, potentially leading to kidney damage.

Purpose of the Study:

  • To investigate the role of gut microbiota in kidney diseases.
  • To understand how gut bacteria contribute to the pathogenesis of conditions like IgA nephropathy and diabetic nephropathy.
  • To explore bacterial metabolites as potential uremic toxins.

Main Methods:

  • Analysis of gut microbiota diversity and composition in patients with chronic kidney disease.
  • Assessment of the metabolic and immunologic functions of gut bacteria.
  • Identification of specific bacterial species and their metabolites associated with kidney disease.

Main Results:

  • Gut microbiota alterations are observed in chronic kidney disease.
  • Specific bacterial compositions and metabolites correlate with kidney disease severity.
  • Gut bacteria contribute to uremic toxin production and immune dysregulation.

Conclusions:

  • Gut microbiota dysbiosis is implicated in the development and progression of kidney diseases.
  • Understanding gut bacteria offers potential for novel therapeutic strategies.
  • Targeting the gut microbiome may help manage uremic toxins and immune responses in kidney patients.